With regard to what symptoms individuals can expect from XE Kinane says it depends on a number of factors including their “genetic profile, previous exposure to the COVID-19 virus, and vaccination record”.
A patient who has been vaccinated or had Covid before is far more likely to experience less severe illness than someone who hasn’t.
READ RELATED: Proteins in MILK have virus inhibiting properties that can help prevent COVID-19
As well as concerns over the impact of XE on the immunocompromised there are also concerns over the further mutation of the coronavirus into a more transmissible variant, one which can evade the protection of vaccines.
On this Kinane says “there is a limit before it [COVID-19] hits an evolutionary bottleneck”.
Source: Daily Express
